Psilocybin Clinical Trial for Mental-Health Workers Approved in Canada

May 24, 2024

Psilocybin Spurs Dynamic Brain ‘Hyperconnectivity’ Linked to Psychedelic Epiphanies

May 24, 2024

Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD

May 17, 2024

BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle

May 15, 2024

Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment

May 9, 2024

Compass Pathways COMP360 Delivers on Phase 2 Results

May 9, 2024